XAIRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends March 31
Beyond Air, Inc.
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$2.13−0.03 (-1.16%)
Close on Oct 19, 2026
- Market cap
- $1.54M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
0.0%
0M of 1M shares
Institutional holders
1
1 new, 0 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
2 buys · 0 sales
Net bought $225.00K
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Avenue Capital Management II, L.P. | 8,072,872 | 8.86% | 13G (passive) amendment | Dec 31, 2024 |
| Bam Gp LLC | 763,266 | 5.30% | 13G (passive) amendment | Jun 30, 2026 |
| Dames GP LLC | 763,266 | 7.25% | 13G (passive) amendment | Mar 31, 2026 |
| Balyasny Asset Management Holdings LP | 763,266 | 9.27% | 13G (passive) amendment | Sep 30, 2025 |
| Alyeska Fund GP, LLC | 7,146,576 | 9.90% | 13G (passive) | Dec 31, 2024 |
| Anand Parekh | 582,638 | 7.27% | 13G (passive) amendment | Dec 31, 2025 |
| Charles Mosseri Marlio | 3,330,250 | 9.21% | 13G (passive) amendment | Dec 31, 2023 |
| Lin Yi-Chien | 145,393 | 14.80% | 13G (passive) amendment | Sep 28, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of XAIR | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| SBI Securities Co., Ltd. | 15 | 0.00% | $7 | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | 0M | 0.0% | 1 / 0 | 0 / 0 | 0M | 0M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Robert Scott Goodman | Chief Executive Officer, Director | 34,822 | 3.64% | Jul 31, 2026 |
| Steven A. Lisi | CEO and Chairman of the Board, Director | 3,327,411 | 347.46% | Nov 6, 2025 |
| Daniel J. Moorhead | Chief Financial Officer | 4,340 | 0.45% | Jul 31, 2026 |
| Michael A. Gaul | Chief Operating Officer | 94,150 | 9.83% | Nov 24, 2025 |
| Douglas Quinton Larson | Chief Financial Officer | 27,548 | 2.88% | Nov 6, 2025 |
| Yoori Lee | Director | 12,654 | 1.32% | Nov 24, 2025 |
| Robert Carey | Director | 5,553,490 | 579.92% | Nov 7, 2025 |
| Erick Lucera | Director | 43,608 | 4.55% | Nov 6, 2025 |
| William P. Forbes | Director | 14,855 | 1.55% | Nov 6, 2025 |
| Ron Bentsur | Director | 144,736 | 15.11% | Nov 26, 2024 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Daniel J. Moorhead Chief Financial Officer | Jul 29, 2026 | Buy | +4,340 | $5.76 | $25.00K | 4,340 |
| Robert Scott Goodman Chief Executive Officer, Director | Jul 29, 2026 | Buy | +34,722 | $5.76 | $200.00K | 34,822 |
| Steven A. Lisi CEO and Chairman of the Board, Director | Jul 21, 2025 | Buy | +6,000 | $3.25 | $19.50K | 3,327,411 |
| Robert Carey Director | Mar 14, 2025 | Buy | +10,000 | $0.26 | $2.60K | 4,076,864 |
| Robert Carey Director | Mar 14, 2025 | Buy | +990,000 | $0.25 | $247.50K | 4,066,864 |
| Michael A. Gaul Chief Operating Officer | Feb 19, 2025 | Buy | +6,000 | $0.38 | $2.28K | 94,150 |
| Robert Carey Director | Sep 26, 2024 | Buy | +1,476,626 | $0.50 | $738.31K | 1,476,626 |
| Steven A. Lisi CEO and Chairman of the Board, Director | Sep 26, 2024 | Buy | +1,476,626 | $0.50 | $738.31K | 3,249,411 |
| Steven A. Lisi CEO and Chairman of the Board, Director | Aug 15, 2024 | Buy | +50,000 | $0.37 | $18.50K | 1,772,785 |
| Erick Lucera Director | Aug 14, 2024 | Buy | +39,266 | $0.40 | $15.71K | 43,608 |
| Steven A. Lisi CEO and Chairman of the Board, Director | Aug 14, 2024 | Buy | +100,000 | $0.39 | $39.00K | 1,722,785 |
| Robert Carey Director | Aug 14, 2024 | Buy | +100,000 | $0.40 | $40.00K | 3,076,864 |
| Robert Carey Director | Mar 20, 2024 | Award | +602,410 | $1.66 | $1.00M | 2,976,864 |
| Douglas Quinton Larson Chief Financial Officer | Mar 20, 2024 | Award | +12,048 | $1.66 | $20.00K | 27,548 |
| Steven A. Lisi CEO and Chairman of the Board, Director | Mar 20, 2024 | Award | +78,314 | $1.66 | $130.00K | 1,614,785 |
| Amir Avniel Chief Business Officer, Director | Dec 28, 2023 | Sale | −13,733 | $2.05 | $28.15K | 0 |
| Amir Avniel Chief Business Officer, Director | Dec 28, 2023 | Sale | −11,267 | $2.06 | $23.21K | 685,760 |
| Jeff Lynn Myers Chief Medical Officer | Dec 27, 2023 | Sale | −3,423 | $2.21 | $7.56K | 46,577 |
| Robert Carey Director | Dec 18, 2023 | Buy | +1,200,000 | $1.64 | $1.97M | 2,374,454 |
| Steven A. Lisi CEO and Chairman of the Board, Director | Dec 18, 2023 | Buy | +77,775 | $1.63 | $126.77K | 1,536,471 |
| Michael A. Gaul Chief Operating Officer | Nov 16, 2023 | Buy | +10,000 | $1.77 | $17.70K | 88,150 |
| Robert Carey Director | Aug 28, 2023 | Buy | +250,000 | $2.70 | $675.00K | 1,225,160 |
| Robert Carey Director | Aug 21, 2023 | Buy | +75,050 | $2.76 | $207.14K | 975,160 |
| Robert Carey Director | Aug 18, 2023 | Buy | +13,614 | $2.64 | $35.94K | 900,110 |
| Michael A. Gaul Chief Operating Officer | Jun 30, 2023 | Buy | +5,000 | $4.51 | $22.55K | 78,150 |
| William P. Forbes Director | Mar 31, 2023 | Buy | +5,000 | $6.67 | $33.35K | 14,855 |
| Robert Carey Director | Mar 30, 2023 | Buy | +10,000 | $6.45 | $64.50K | 886,496 |
| Amir Avniel Chief Business Officer, Director | Mar 29, 2023 | Award | +240,000 | – | – | 697,027 |
| Robert Carey Director | Mar 29, 2023 | Buy | +10,000 | $6.30 | $63.00K | 876,496 |
| Yoori Lee Director | Mar 28, 2023 | Buy | +3,115 | $6.34 | $19.75K | 12,654 |
| Jeff Lynn Myers Chief Medical Officer | Mar 27, 2023 | Award | +50,000 | – | – | 50,000 |
| Michael A. Gaul Chief Operating Officer | Mar 24, 2023 | Buy | +1,000 | $6.15 | $6.15K | 73,150 |
| Ron Bentsur Director | Mar 20, 2023 | Buy | +2,300 | $6.48 | $14.90K | 144,736 |
| Steven A. Lisi CEO and Chairman of the Board, Director | Mar 17, 2023 | Buy | +10,000 | $6.46 | $64.60K | 1,458,696 |
| William P. Forbes Director | Mar 17, 2023 | Buy | +5,000 | $6.46 | $32.30K | 9,855 |
| Robert Carey Director | Mar 16, 2023 | Gift | −28,656 | – | – | 835,840 |
| Erick Lucera Director | Mar 16, 2023 | Buy | +2,000 | $6.82 | $13.64K | 4,342 |
| Robert Carey Director | Mar 14, 2023 | Buy | +10,000 | $6.85 | $68.50K | 866,496 |
| Amir Avniel Chief Business Officer, Director | Mar 13, 2023 | Buy | +1,000 | $6.40 | $6.40K | 457,027 |
| Robert Carey Director | Mar 13, 2023 | Buy | +4,173 | $6.15 | $25.66K | 856,496 |
| Steven A. Lisi CEO and Chairman of the Board, Director | Mar 8, 2023 | Buy | +5,000 | $5.89 | $29.45K | 1,447,849 |
| Robert Carey Director | Mar 8, 2023 | Buy | +10,000 | $5.95 | $59.50K | 852,323 |
| Steven A. Lisi CEO and Chairman of the Board, Director | Mar 7, 2023 | Buy | +45,000 | $5.98 | $269.10K | 1,442,849 |
| Michael A. Gaul Chief Operating Officer | Mar 7, 2023 | Buy | +8,000 | $5.86 | $46.88K | 72,150 |
| Steven A. Lisi CEO and Chairman of the Board, Director | Feb 16, 2023 | Sale | −48,596 | $6.10 | $296.44K | 1,397,849 |
| Robert Carey Director | Dec 7, 2022 | Buy | +20,000 | $5.75 | $115.00K | 842,323 |
| Robert Carey Director | Dec 2, 2022 | Gift | −16,000 | – | – | 864,496 |
| Robert Carey Director | Nov 29, 2022 | Buy | +15,000 | $5.75 | $86.25K | 822,323 |
| Robert Carey Director | Nov 28, 2022 | Buy | +15,000 | $5.75 | $86.25K | 807,323 |
| Robert Carey Director | Nov 18, 2022 | Buy | +20,000 | $5.80 | $116.00K | 792,323 |
| Robert Carey Director | Nov 17, 2022 | Buy | +20,000 | $5.90 | $118.00K | 772,323 |
| Robert Carey Director | Nov 16, 2022 | Buy | +10,000 | $6.00 | $60.00K | 752,323 |
| Michael A. Gaul Chief Operating Officer | Aug 22, 2022 | Buy | +2,000 | $9.42 | $18.84K | 64,150 |
| Amir Avniel COO and President, Director | Jun 30, 2022 | Sale | −2,600 | $6.57 | $17.08K | 13,733 |
| Amir Avniel COO and President, Director | Jun 30, 2022 | Sale | −65,500 | $6.50 | $425.75K | 408,027 |
| Robert Carey Director | Jun 30, 2022 | Buy | +175,000 | $6.45 | $1.13M | 742,323 |
| Ron Bentsur Director | Jun 30, 2022 | Sale | −40,000 | $6.53 | $261.20K | 142,436 |
| Steven A. Lisi CEO and Chairman of the Board, Director | Jun 30, 2022 | Buy | +73,000 | $6.63 | $483.99K | 1,446,445 |
| Robert Carey Director | May 3, 2022 | Gift | −6,000 | – | – | 880,496 |
| Robert Carey Director | Apr 5, 2022 | Buy | +20,000 | $6.71 | $134.20K | 567,323 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Amir Avniel Officer | Aug 22, 2024 | 180,415 | $83.44K | Aug 22, 2024 | Private placement |
| Amir Avniel Director | Dec 29, 2023 | 50,000 | $108.50K | Dec 28, 2023 | Private Placement |